Becton Dickinson ROA 2012-2026 | BDX
Current and historical return on assets (ROA) values for Becton Dickinson (BDX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Becton Dickinson ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2026-03-31 | $1.14B | $53.98B | 2.11% |
| 2025-12-31 | $1.76B | $54.88B | 3.20% |
| 2025-09-30 | $1.68B | $54.84B | 3.06% |
| 2025-06-30 | $1.59B | $55.33B | 2.86% |
| 2025-03-31 | $1.50B | $55.50B | 2.70% |
| 2024-12-31 | $1.73B | $55.42B | 3.12% |
| 2024-09-30 | $1.71B | $54.83B | 3.11% |
| 2024-06-30 | $1.41B | $53.70B | 2.63% |
| 2024-03-31 | $1.32B | $53.06B | 2.48% |
| 2023-12-31 | $1.22B | $53.12B | 2.29% |
| 2023-09-30 | $1.42B | $53.33B | 2.67% |
| 2023-06-30 | $1.58B | $53.37B | 2.96% |
| 2023-03-31 | $1.53B | $53.41B | 2.86% |
| 2022-12-31 | $1.52B | $53.51B | 2.84% |
| 2022-09-30 | $1.69B | $53.57B | 3.15% |
| 2022-06-30 | $1.67B | $53.80B | 3.10% |
| 2022-03-31 | $1.83B | $54.09B | 3.38% |
| 2021-12-31 | $1.68B | $54.12B | 3.10% |
| 2021-09-30 | $2.00B | $54.47B | 3.68% |
| 2021-06-30 | $1.87B | $54.50B | 3.42% |
| 2021-03-31 | $1.64B | $54.41B | 3.01% |
| 2020-12-31 | $1.51B | $54.06B | 2.79% |
| 2020-09-30 | $0.77B | $53.36B | 1.44% |
| 2020-06-30 | $0.79B | $52.80B | 1.49% |
| 2020-03-31 | $0.92B | $52.37B | 1.76% |
| 2019-12-31 | $0.76B | $52.14B | 1.46% |
| 2019-09-30 | $1.08B | $52.38B | 2.07% |
| 2019-06-30 | $0.78B | $52.92B | 1.48% |
| 2019-03-31 | $0.93B | $53.35B | 1.74% |
| 2018-12-31 | $0.90B | $53.85B | 1.66% |
| 2018-09-30 | $0.16B | $54.45B | 0.29% |
| 2018-06-30 | $0.62B | $50.41B | 1.23% |
| 2018-03-31 | $-0.10B | $46.21B | -0.22% |
| 2017-12-31 | $0.29B | $38.60B | 0.76% |
| 2017-09-30 | $1.03B | $30.84B | 3.34% |
| 2017-06-30 | $0.76B | $27.80B | 2.73% |
| 2017-03-31 | $1.32B | $25.01B | 5.26% |
| 2016-12-31 | $1.31B | $25.54B | 5.13% |
| 2016-09-30 | $0.98B | $25.97B | 3.76% |
| 2016-06-30 | $1.14B | $26.19B | 4.34% |
| 2016-03-31 | $0.81B | $26.46B | 3.06% |
| 2015-12-31 | $0.69B | $26.97B | 2.55% |
| 2015-09-30 | $0.70B | $25.09B | 2.77% |
| 2015-06-30 | $0.82B | $21.58B | 3.78% |
| 2015-03-31 | $1.08B | $17.90B | 6.03% |
| 2014-12-31 | $1.15B | $13.89B | 8.28% |
| 2014-09-30 | $1.19B | $12.28B | 9.65% |
| 2014-06-30 | $0.97B | $12.20B | 7.98% |
| 2014-03-31 | $0.95B | $12.01B | 7.91% |
| 2013-12-31 | $0.94B | $11.85B | 7.92% |
| 2013-09-30 | $1.29B | $11.75B | 11.01% |
| 2013-06-30 | $1.49B | $11.55B | 12.92% |
| 2013-03-31 | $1.52B | $11.41B | 13.29% |
| 2012-12-31 | $1.53B | $11.30B | 13.55% |
| 2012-09-30 | $1.17B | $11.25B | 10.40% |
| 2012-06-30 | $1.18B | $11.02B | 10.72% |
| 2012-03-31 | $1.20B | $10.92B | 10.97% |
| 2011-12-31 | $1.22B | $10.70B | 11.38% |
| 2011-09-30 | $1.27B | $10.37B | 12.26% |
| 2011-06-30 | $1.37B | $10.17B | 13.45% |
| 2011-03-31 | $1.33B | $9.78B | 13.63% |
| 2010-12-31 | $1.32B | $9.42B | 13.99% |
| 2010-09-30 | $1.32B | $9.18B | 14.36% |
| 2010-06-30 | $1.24B | $9.09B | 13.61% |
| 2010-03-31 | $1.27B | $9.05B | 14.06% |
| 2009-12-31 | $1.24B | $8.71B | 14.19% |
| 2009-09-30 | $1.23B | $8.35B | 14.75% |
| 2009-06-30 | $1.20B | $8.00B | 14.95% |
| 2009-03-31 | $1.15B | $7.82B | 14.73% |
| 2008-12-31 | $1.17B | $7.88B | 14.82% |
| 2008-09-30 | $1.13B | $7.85B | 14.35% |
| 2008-06-30 | $1.11B | $7.71B | 14.34% |
| 2008-03-31 | $1.05B | $7.46B | 14.12% |
| 2007-12-31 | $1.02B | $7.24B | 14.08% |
| 2007-09-30 | $0.89B | $7.05B | 12.63% |
| 2007-06-30 | $0.81B | $6.93B | 11.62% |
| 2007-03-31 | $0.77B | $6.70B | 11.43% |
| 2006-12-31 | $0.68B | $6.49B | 10.43% |
| 2006-09-30 | $0.75B | $6.35B | 11.85% |
| 2006-06-30 | $0.73B | $6.18B | 11.77% |
| 2006-03-31 | $0.71B | $6.12B | 11.61% |
| 2005-12-31 | $0.75B | $6.09B | 12.22% |
| 2005-09-30 | $0.72B | $6.03B | 11.97% |
| 2005-06-30 | $0.64B | $5.94B | 10.78% |
| 2005-03-31 | $0.56B | $5.86B | 9.54% |
| 2004-12-31 | $0.54B | $5.79B | 9.26% |
| 2004-09-30 | $0.47B | $5.70B | 8.18% |
| 2004-06-30 | $0.56B | $5.65B | 9.91% |
| 2004-03-31 | $0.58B | $5.61B | 10.35% |
| 2003-12-31 | $0.56B | $5.50B | 10.15% |
| 2003-09-30 | $0.55B | $5.36B | 10.21% |
| 2003-06-30 | $0.52B | $5.22B | 9.90% |
| 2003-03-31 | $0.51B | $5.07B | 10.01% |
| 2002-12-31 | $0.49B | $4.97B | 9.95% |
| 2002-09-30 | $0.48B | $4.89B | 9.82% |
| 2002-06-30 | $0.48B | $4.83B | 9.95% |
| 2002-03-31 | $0.48B | $4.78B | 10.03% |
| 2001-12-31 | $0.46B | $4.72B | 9.82% |
| 2001-09-30 | $0.40B | $4.68B | 8.56% |
| 2001-06-30 | $0.35B | $4.61B | 7.66% |
| 2001-03-31 | $0.35B | $4.58B | 7.63% |
| 2000-12-31 | $0.35B | $4.55B | 7.78% |
| 2000-09-30 | $0.39B | $4.52B | 8.67% |
| 2000-06-30 | $0.38B | $4.51B | 8.52% |
| 2000-03-31 | $0.30B | $4.39B | 6.91% |
| 1999-12-31 | $0.27B | $4.29B | 6.39% |
| 1999-09-30 | $0.28B | $4.15B | 6.63% |
| 1999-06-30 | $0.29B | $4.00B | 7.23% |
| 1999-03-31 | $0.25B | $3.91B | 6.30% |
| 1998-12-31 | $0.25B | $3.67B | 6.76% |
| 1998-09-30 | $0.24B | $3.45B | 6.84% |
| 1998-06-30 | $0.24B | $3.26B | 7.21% |
| 1998-03-31 | $0.32B | $3.09B | 10.19% |
| 1997-12-31 | $0.31B | $3.00B | 10.21% |
| 1997-09-30 | $0.30B | $2.93B | 10.23% |
| 1997-06-30 | $0.30B | $2.89B | 10.33% |
| 1997-03-31 | $0.31B | $2.85B | 10.69% |
| 1996-12-31 | $0.30B | $2.87B | 10.34% |
| 1996-09-30 | $0.28B | $2.90B | 9.79% |
| 1996-06-30 | $0.28B | $2.93B | 9.70% |
| 1996-03-31 | $0.27B | $2.96B | 9.25% |
| 1995-12-31 | $0.26B | $3.01B | 8.77% |
| 1995-09-30 | $0.25B | $3.03B | 8.35% |
| 1995-06-30 | $0.25B | $3.07B | 8.21% |
| 1995-03-31 | $0.24B | $3.07B | 7.91% |
| 1994-12-31 | $0.24B | $3.06B | 7.68% |
| 1994-09-30 | $0.23B | $3.05B | 7.44% |
| 1994-06-30 | $0.22B | $3.03B | 7.15% |
| 1994-03-31 | $0.22B | $3.03B | 7.14% |
| 1993-12-31 | $0.22B | $3.05B | 7.04% |
| 1993-09-30 | $0.07B | $3.07B | 2.31% |
| 1993-06-30 | $0.07B | $3.09B | 2.17% |
| 1993-03-31 | $0.07B | $3.10B | 2.13% |
| 1992-12-31 | $0.06B | $3.05B | 2.03% |
| 1992-09-30 | $0.20B | $3.00B | 6.74% |
| 1992-06-30 | $0.19B | $2.90B | 6.63% |
| 1992-03-31 | $0.19B | $2.79B | 6.62% |
| 1991-12-31 | $0.18B | $2.74B | 6.64% |
| 1991-09-30 | $0.19B | $2.68B | 7.05% |
| 1991-06-30 | $0.19B | $2.64B | 7.17% |
| 1991-03-31 | $0.19B | $2.59B | 7.22% |
| 1990-12-31 | $0.18B | $2.52B | 7.30% |
| 1990-09-30 | $0.18B | $2.45B | 7.48% |
| 1990-06-30 | $0.18B | $2.37B | 7.40% |
| 1990-03-31 | $0.21B | $2.29B | 9.34% |
| 1989-12-31 | $0.21B | $2.23B | 9.56% |
| 1989-09-30 | $0.21B | $2.19B | 9.72% |
| 1989-06-30 | $0.21B | $2.14B | 10.00% |
| 1989-03-31 | $0.17B | $2.10B | 8.15% |
| 1988-12-31 | $0.17B | $2.06B | 8.03% |
| 1988-09-30 | $0.16B | $2.00B | 8.07% |
| 1988-06-30 | $0.15B | $1.95B | 7.63% |
| 1988-03-31 | $0.14B | $1.90B | 7.52% |
| 1987-12-31 | $0.14B | $1.85B | 7.58% |
| 1987-09-30 | $0.15B | $1.79B | 8.25% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $43.913B | $21.840B |
| Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |